Novo-Nordisk stock at EUR 34.60 ahead of the Xetra open: drugmaker
Published on 10/19/2026 at 08:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSBusiness model and trading date
- Novo Nordisk develops and supplies medicines for diabetes, obesity, cardiovascular conditions, and rare diseases.
- The pre-market indication is dated October 19, 2026.
- Novo-Nordisk stock trades pre-market at EUR 34.60 at 8:04 a.m. CEST at Lang & Schwarz on October 19, 2026.
Novo Nordisk develops, manufactures and distributes medicines for diabetes, obesity, cardiovascular conditions and rare diseases, along with related medical devices and digital solutions. Novo-Nordisk stock trades pre-market at EUR 34.60 at 8:04 a.m. CEST at Lang & Schwarz on October 19, 2026.
Ahead of the Xetra open
The pre-market indication is dated October 19, 2026. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Novo-Nordisk stock.
Business and the day
The company earns revenue from pharmaceutical products and related medical equipment across its Diabetes and Obesity Care and Rare Disease businesses. Its portfolio includes treatments for diabetes, obesity, cardiovascular ailments, rare blood disorders and endocrine conditions. Market context: Latest market reports.
